Drug
Aln Vsp02
Aln Vsp02: highest development phase Phase 1, developed by Alnylam Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Alnylam Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ALN-VSP02 NCT01158079 | Phase 1 | Solid Tumors |
| ALN-VSP02 NCT00882180 | Phase 1 | Solid Tumors |
Latest
No recent events.
Follow Aln Vsp02 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.